Countries Japan

Ajinomoto Bio-Pharma Services Sweeps CDMO Leadership Awards in Unprecedented Six-Category Win

Ajinomoto Bio-Pharma Services ("Aji Bio-Pharma"), a leading provider of biopharmaceutical contract development and manufacturing services, received CDMO Le...

 March 13, 2024 | News

Ono Pharmaceutical Forms Strategic Alliance with Harvard University for Drug Discovery

 Ono Pharmaceutical announced that it entered into a five-year, university-wide strategic research alliance agreement with Harvard University&nbs...

 March 12, 2024 | News

Eisai Boosts Support for Alzheimer's Diagnosis with $15 Million Investment in C2N Diagnostics

Eisai Co., Ltd. announced a significant step forward in the fight against Alzheimer's disease (AD) today, with its U.S. subsidiary Eisai Inc. committing up...

 March 07, 2024 | News

MGI Tech & Juntendo University: Transforming Care for Rare Disease Patients

While they are identified and addressed differently around the world, there are over known 6,000 rare diseases – characterized by a wide range of dis...

 February 29, 2024 | News

Ono Pharmaceutical Partners with InveniAI to Revolutionize Drug Discovery Using AI

Ono Pharmaceutical Co., Ltd. (Osaka, Japan; President and CEO: Gyo Sagara; "Ono") has announced a strategic partnership with the AI-driven company InveniAI...

 February 22, 2024 | News

Japan Accelerates Approval Process for Groundbreaking Urothelial Cancer Treatment by Astellas

Astellas Pharma Inc. (TSE:4503, President and CEO: Naoki Okamura, "Astellas")  announced that Japan's Ministry of Health, Labour a...

 February 19, 2024 | News

Japan Becomes First in the World to Approve Dupixent® for Chronic Spontaneous Urticaria (CSU)

  Approval based primarily on results from Phase 3 trial showing Dupixent significantly reduced itch compared to placebo CSU is the fifth appr...

 February 17, 2024 | News

eGenesis and PorMedTec Achieve Breakthrough in Genetically Engineered Porcine Donors Production in Japan

eGenesis and PorMedTec Announce Successful Production of Genetically Engineered Porcine Donors in Japan Critical milestone in establishing eGenesis ...

 February 14, 2024 | News

Otsuka's AVP-786 Falls Short in Phase 3 Trial for Alzheimer's Agitation

Otsuka Pharmaceutical Development & Commercialization, Inc., (OPDC) and its parent company Otsuka Pharmaceutical, Co. Ltd. (Otsuka) have released the t...

 February 13, 2024 | News

Sysmex and Hitachi High-Tech Collaborate on New Genetic Testing Systems

  The development of assay reagents using next-generation sequencers (NGS) has seen significant advancements in recent years. However, challenges suc...

 February 08, 2024 | News

Bruker Corporation Acquires Nanophoton Expanding Raman Microscopy Portfolio and Global Reach

Bruker Corporation announced the acquisition of Nanophoton Corporation, a pioneer focused on advanced research Raman microscopy systems. Headquar...

 February 08, 2024 | News

SMC Laboratories Unveils STAM™-HCC/IO+ Mouse for Advancing Liver Cancer Drug Development in Immuno-Oncology

 The company specializes in liver-related services and has evaluated test substances in over 15 MOA categories as well as over 270 target molecules us...

 February 07, 2024 | News

Travere Therapeutics Licenses Sparsentan to Renalys Pharma for Japan, South Korea, Taiwan, and Southeast Asia

Travere Therapeutics,announced that it has entered into an exclusive licensing agreement with Renalys Pharma, Inc., to bring sparsentan, a dual endothelin ...

 January 29, 2024 | News

Eisai Seeks Approval in Japan for Ultrahigh-Dose Mecobalamin in ALS

This application is based on the results of JETALS (The Japan Early-Stage Trial of Ultrahigh-Dose Methylcobalamin for ALS), a Phase III trial to evaluate e...

 January 29, 2024 | News


Stay Connected

Sign up to our free newsletter and get the latest news sent direct to your inbox

Show

Forgot your password?

Show

Show

Lost your password? Please enter your email address. You will receive a link to create a new password.

Back to log-in

Close